"Intraductal papilloma"

Ultrasound-Guided Vacuum-Assisted Excision to Treat Intraductal Papilloma. To evaluate the value of ultrasound-guided vacuum-assisted excision (US-guided VAE) in the treatment of intraductal papillomas, including intraductal papillomas with atypical ductal hyperplasia (ADH), and to evaluate the lesion characteristic features affecting the local recurrence rate. Between August 2011 and December 2020, 91 lesions of 91 patients underwent US-guided VAE and were diagnosed with intraductal papilloma with or without ADH. The recurrence rate of intraductal papilloma was evaluated on follow-up US. The lesion characteristic features were analyzed to identify the factors affecting the local recurrence rate. The local recurrence rate of intraductal papillomas removed by US-guided VAE was 7.7% (7/91

Comparison of vacuum-assisted excision (VAE) and breast lesion excision system (BLES) in the treatment of intraductal papillomas. This study aims to compare the feasibility of VAE and BLES in the treatment of intraductal papillomas. Patients with a suspected intraductal papilloma who underwent a BLES or a VAE procedure were included in this retrospective study. The BLES procedures were performed in the treatment of intraductal papillomas. In most non-malignant lesions surgery was avoided, but VAE was feasible in larger lesions than BLES. However, follow-up ultrasound was needed more often after VAE. The histopathologic assessment is more reliable after BLES, as the lesion is removed as a single sample.

Management of intraductal papilloma of the breast Management of intraductal papilloma of the breast Homepage ..

Benign Breast Intraductal Papillomas Without Atypia at Core Needle Biopsies: Is Surgical Excision Necessary? The aim of this study was to determine the upgrade rate of image-guided core needle biopsy (CNB)-proven benign breast intraductal papillomas (IDPs) without atypia to high-risk benign lesions or malignancy after surgical excision. A retrospective database search at a single institution

Intraductal papilloma arising from the accessory parotid gland: A case report and literature review. Intraductal papillomas of the accessory parotid glands are extremely rare benign tumors that are most commonly derived from minor salivary glands and are easily misdiagnosed as other diseases. Studying these lesions by pathology and immunohistochemistry can raise awareness of the disease, reduce the rate of misdiagnosis, and provide more precise treatments. A 35-year-old man first presented to our hospital with a 6-month history of a painless mass on his left parotid gland. The patient was diagnosed with intraductal papilloma of the accessory parotid gland by pathology and immunohistochemistry. The mass was completely resected. After 2 years of postoperative follow-up, the patient recovered well

Mammographic and ultrasound findings in poroid hidradenoma of the breast mimicking intraductal papilloma and papillary carcinoma: A case report. Poroid hidradenoma (PH) is a rare variant of benign sweat gland neoplasm without connection to the epidermis. This tumor presents clinically as a solitary lesion with a cystic component located in the subcutaneous layer abutting the skin. On ultrasound , it appears as a circumscribed complex cystic and solid mass abutting the dermis. The occurrence of PH in the breast is very rare. Its features overlap with intraductal papilloma and papillary carcinoma. A 66-year-old woman presented with a palpable lump in her right breast. Clinical examination revealed dark bluish dome-shaped nodule which presented as circumscribed round isodense mass on mammography

Use of immunohistochemical analysis of CK5/6, CK14, and CK34betaE12 in the differential diagnosis of solid papillary carcinoma in situ from intraductal papilloma with usual ductal hyperplasia of the breast The aim of this study was to use immunohistochemistry to differentiate solid papillary carcinoma in situ from intraductal papilloma with usual ductal hyperplasia (IPUDH). Three types of high

Benign Intraductal Papilloma without Atypia on Core Needle Biopsy Has a Low Rate of Upgrading to Malignancy after Excision The management of benign intraductal papilloma (IDP) without atypia diagnosed on core needle biopsy (CNB) remains controversial. This study was performed to evaluate the rate of upgrading to malignancy or high-risk lesions after excision and to identify factors associated

Rare case of male breast intraductal papilloma progressing to invasive ductal carcinoma: A radiologic-pathologic correlation Although male breast cancer represents only 0.5%-1% of all breast cancer cases in the United States, the incidence of this disease is slowly rising [1]. Because of its extremely low prevalence, screening and treatment guidelines are not well established. Thus, analyzing cases of male breast cancer can accelerate this process. We present a case of a 52-year-old man, initially diagnosed with biopsy-confirmed intraductal papilloma without atypia, who presented 3 years later with progression of this benign lesion to ductal carcinoma in situ and development of de novo invasive ductal carcinoma. This report stresses the importance of symptom detection and risk factor

Breast Lesion Excision System in the diagnosis and treatment of intraductal papillomas - A feasibility study. This study aims to evaluate the feasibility of Breast Lesion Excision System (BLES) in the treatment of intraductal papillomas. All patients with a needle biopsy -based suspicion of an intraductal papilloma who consequently underwent a BLES procedure at Helsinki University Hospital between 2011 and 2016 were included in this retrospective study. The purpose of the BLES procedure was either to excise the entire lesion or in few cases to achieve better sampling. In total, 74 patients underwent 80 BLES procedures. Pathological diagnosis after the BLES biopsy confirmed an intraductal papilloma without atypia in 43 lesions, whereas 10 lesions were upgraded to high-risk lesions (HRL

Primary Osteosarcoma of the Breast Arising in an Intraductal Papilloma Primary osteosarcoma of the breast is extremely rare, and an osteosarcoma arising from an intraductal papilloma is exceptional. A 72-year-old Saudi Arabian woman presented with a solid, bone-containing breast mass that was diagnosed as primary osteosarcoma of the breast on biopsy. She had a history of untreated intraductal papilloma. Treatment was completed with a modified mastectomy after excluding extramammary metastases. However, she subsequently developed multiple recurrent lesions at the same site. Primary osteogenic sarcomas of the breast are very rare. Although the main treatment is resection the optimal management remains uncertain and prognosis is poor.

Intraductal Papilloma with Benign Pathology on Breast Core Biopsy: To Excise or Not? The management of intraductal papillomas on core biopsy continues to be controversial. Papillomas with atypia are typically excised. However, it is unclear whether surgical excision is warranted for benign lesions. A retrospective review of our institution's pathology and radiology databases from January 2009

Breast intraductal papillomas without atypia in radiologic-pathologic concordant core-needle biopsies: Rate of upgrade to carcinoma at excision. The surgical management of mammary intraductal papilloma without atypia (IDP) identified at core-needle biopsy (CNB) is controversial. This study assessed the rate of upgrade to carcinoma at surgical excision (EXC). This study identified women with a CNB diagnosis of intraductal papilloma without atypia or carcinoma at a cancer center between 2003 and 2013. Radiologic-pathologic concordance was assessed for all cases, and discordant cases were excluded. The radiologic and clinicopathologic features of patients with a CNB diagnosis of IDP were correlated with an upgrade to carcinoma at EXC. The study population consists of 189 women with 196 IDPs

Intraductal papilloma of the male breast We report the case of a 29-year-old male patient who presented with a painless lump of his left breast that was found to be an intraductal papilloma. This is an extremely rare, but benign disease in the male breast. We subsequently discuss radiologic tests and treatment options.

Diagnostic dilemmas in Intraductal papillomas of the breast - Experience at Sultan Qaboos University Hospital in the Sultanate of Oman The aim of this retrospective study was to correlate the significance and accuracy of the colour of nipple discharge and breast ultrasound imaging in the diagnosis of intraductal papilloma. This is a retrospective study of 34 patients who underwent 36 age of the patients was 44(27-73) years old. Twenty-seven out 36 (75%) patients had presented with nipple discharge, 14 out 27 (52%) had blood stained nipple discharge and 13(48%) with coloured discharge (yellow, brown and green), 9 patients had no discharge. The final histopathology showed intraductal papilloma 13 (36%), duct ectasia 18(50%), DCIS 1 (2.7%), fibrocystic disease 3(8.3%) and LCIS 1

Malignant upgrade rate and associated clinicopathologic predictors for concordant intraductal papilloma without atypia a systematic review and meta-analysis. PROSPEROInternational prospective register of systematic reviews Print | PDFMalignant upgrade rate and associated clinicopathologic predictors for concordant intraductal papilloma without atypia; a systematic review and meta . Further detail is provided here.CitationNiamh Keating, Jevan Cevik. Malignant upgrade rate and associated clinicopathologic predictors for concordant intraductal papilloma without atypia; a systematic review and meta-analysis.. PROSPERO 2023 CRD42023460694 Available from: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023460694Review questionIn women with a tissue biopsy diagnosis

Intraductal Papilloma Intraductal Papilloma * Versions * Standard Desktop * Legacy Desktop * Mobile Web * Iphone/Ipad App * * Help Toggle navigation * * Home * Books: A to N * Cardiovascular Medicine * Dentistry * Dermatology * Emergency Medicine * Endocrinology * Gastroenterology * Geriatric Medicine to Palliative Care * * Administration * Patient Satisfaction * Documentation 4 * * advertisement * Home * Gynecology Book * Breast Disorders Chapter * Intraductal Papilloma Intraductal Papilloma Aka: Intraductal Papilloma Gynecology Breast Disorders Chapter * Congenital Abnormality * Congenital Breast Changes * Nipple Inversion

A prolapsed intraductal papilloma: a case report Intraductal papillomas (IP) are benign papillary lesions caused by proliferation of mammary ductal epithelium. IP occurs in the breast tissue. Prolapse of IP from nipple can be rarely seen. IPs are generally treated with total excision. A 31-year-old female patient was admitted to our clinic because of a protruded lesion from the nipple of her right breast. On her breast examination, an 8 mm- prolapsed mass was seen on the areola of her right breast. Breast ultrasonography showed no other lesions in the breast. The patient was operated with initial diagnosis of IP. The prolapsed mass, the overlying nipple skin and related ductus were totally excised under local anesthesia. Histopathological examination of the specimen revealed intraductal

Intraductal Papilloma Intraductal Papilloma * Versions * Standard Desktop * Legacy Desktop * Mobile Web * Iphone/Ipad App * * Help Toggle navigation * * Home * Books: A to N * Cardiovascular Medicine * Dentistry * Dermatology * Emergency Medicine * Endocrinology * Gastroenterology * Geriatric Medicine to Palliative Care * * Administration * Patient Satisfaction * Documentation 4 * * advertisement * Home * Gynecology Book * Breast Disorders Chapter * Intraductal Papilloma Intraductal Papilloma Aka: Intraductal Papilloma Gynecology Breast Disorders Chapter * Congenital Abnormality * Congenital Breast Changes * Nipple Inversion

Completely Removing Solitary Intraductal Papillomas Using the Mammotome System Guided by Ultrasonography Is Feasible and Safe. Because of the potential for an intraductal papilloma to progress to malignancy and the likelihood of detecting unexpected coexisting malignant disease, complete removal of the intraductal papilloma is safer than merely sampling it. The purpose of this study was to estimate the feasibility and safety of excising a solitary intraductal papilloma using the Mammotome system guided by ultrasonography (US). We retrospectively reviewed the clinical information of 136 patients who underwent excision of solitary intraductal papillomas using the 8-gauge probe with the US-guided Mammotome system between December 2005 and December 2011 at our institution. Their lesions had